文献速递肾小球疾病

狼疮肾炎维持治疗撤药后复发:重复肾活检的前瞻性队列研究

A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy.
PubMed 文献 · Kidney Int · 2018-07-23

该前瞻性观察队列纳入临床完全缓解至少12个月且已接受免疫抑制至少36个月的系统性红斑狼疮肾炎(LN)患者,行第二次肾活检后逐渐撤除维持治疗并随访24个月。二次活检NIH活动指数>2者全部复发,活动指数与SLE病程为独立预测因素,预测方程敏感度100%、特异度88%、误分类率8.3%。

要点

  • 临床缓解的LN患者二次活检仍可有残留组织学活动,且与撤药后复发相关。
  • 二次活检NIH活动指数>2者全部出现LN复发。
  • 基于活动指数与SLE病程的预测方程或可辅助决定维持治疗撤除。

核心结论

  • 重复肾活检可能有助于管理LN维持免疫抑制,组织学缓解者或可考虑撤除治疗。

主要发现

  • 36例完成者中11例发生LN复发,其中10例二次活检仍有残留组织学活动。
  • 二次活检NIH活动指数>2的患者全部复发。
  • 二次活检时的活动指数与SLE病程为复发的独立预测因素。
  • 基于上述变量的预测方程区分复发与否的敏感度100%、特异度88%、误分类率8.3%。

关键数值与推荐

  • 入组条件:III/IV型LN、临床完全缓解至少12个月、已接受免疫抑制至少36个月。
  • 撤药后前瞻性随访24个月观察LN复发。

临床怎么用

  • 对临床缓解的III/IV型LN患者,可考虑重复肾活检评估残留组织学活动以辅助维持治疗决策。
  • 组织学缓解者或可作为撤除维持治疗的候选人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

One of the most difficult management issues in lupus nephritis (LN) is the optimal duration of maintenance immunosuppression after patients are in clinical remission. Most patients receive immunosuppression for years, based mainly on expert opinion. Prospective data are unavailable. Complicating this issue are data that patients in clinical remission can still have histologically active LN; however, the implications of this are unknown. To study this, the Lupus Flares and Histological Renal Activity at the end of Treatment study (ClinicalTrial.gov, NCT02313974) was designed to examine whether residual histologic activity predisposes to LN flares in class III and IV LN. Patients in complete clinical remission for at least 12 months who had received at least 36 months of immunosuppression were eligible. Patients consented to a second kidney biopsy, were tapered off maintenance immunosuppression and were then followed prospectively for LN flares over 24 months. Forty-four patients were enrolled, and 36 completed the study. LN flares occurred in 11 patients, and ten of these had residual histologic activity on the second biopsy. All patients with an NIH activity index over two flared. The activity index and duration of systemic lupus erythematosus at the second biopsy were independent predictors of flare. A predictive equation based on these variables discriminated between flare and no flare with a sensitivity of 100%, specificity of 88%, and a misclassification rate of 8.3%. Thus, a repeat kidney biopsy may be useful in managing maintenance immunosuppression in LN, and patients in histologic remission may be candidates for withdrawal of therapy.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. De Rosa M, Azzato F, Toblli JE, et al. A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy. Kidney Int. 2018. PMID: 30045812. doi:10.1016/j.kint.2018.05.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。